Wednesday 26 February 2020
3:00 PM to 4:00 PM
Sometimes little things can make a big difference. That’s certainly the case in clinical research where the emergence of an industry-specific Application Identifier (AI7240) that allows the adoption of the GS1 2D Data Matrix barcode for clinical trial labeling could be a catalyst for major operational gains.
Major players like Pfizer and Sanofi have recognized the opportunity and strengthened their labeling capabilities by adopting the GS1 barcode standards. In the process, they’re unlocking downstream benefits in productivity, reduction in data error and patient care amongst other benefits. It’s important that the industry works in conjunction with change and follows the example the early adopters have set in utilising a proven global standard.
In this free webinar, featured speakers from GS1 and PRISYM ID will explain the new clinical trial GS1 barcode standards, the drivers for releasing them and how AI7240 provides scope for additional checks that protects the integrity of the clinical supply chain, removes data entry errors and allows faster drug dispensing and tracking through its clinical trial life cycle.